IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $36,000 | -89.8% | 10,100 | -29.2% | 0.00% | -81.8% |
| Q3 2021 | $352,000 | +60.0% | 14,264 | -79.0% | 0.01% | +57.1% |
| Q2 2021 | $220,000 | +12.8% | 67,800 | -62.2% | 0.01% | -36.4% |
| Q1 2021 | $195,000 | -89.7% | 179,600 | -33.6% | 0.01% | -79.6% |
| Q4 2020 | $1,885,000 | +4497.6% | 270,300 | +1444.6% | 0.05% | +2600.0% |
| Q3 2020 | $41,000 | +173.3% | 17,500 | -8.9% | 0.00% | +100.0% |
| Q2 2020 | $15,000 | -96.8% | 19,200 | -77.6% | 0.00% | -96.8% |
| Q1 2020 | $465,000 | +87.5% | 85,600 | +19.7% | 0.03% | +121.4% |
| Q4 2019 | $248,000 | +1205.3% | 71,500 | +42.7% | 0.01% | +1300.0% |
| Q1 2018 | $19,000 | – | 50,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |